New treatment may relieve chronic shortness of breath

People experiencing chronic shortness of breath may soon have a new way to help alleviate their discomfort, according to a Penn State College of Medicine pulmonology researcher.

, or , has various causes but few treatment options. People with chronic respiratory and are the most often affected. Generally these patients experience some change in the way their lungs function. In order to compensate for these changes, the sends information to the nervous system that causes dyspnea.

"Currently there is no specific treatment for dyspnea besides giving the patient morphine, which has many side effects and remains very controversial," said Philippe Haouzi, professor and physician of pulmonary and . "We suggest modifying the perception of shortness of breath by stimulating a specific region of the neck, akin to an approach used for the treatment of pain."

The skin is divided into sections, known as dermatomes. and muscles share similar nerves to and from regions of the spinal cord with specific dermatomes. Gentle of a dermatome blocks the transmission of certain types of information coming from the internal organs and the muscles corresponding to the same dermatome.

As the diaphragm has evolved in mammals, "the dermatome corresponding to the diaphragmatic muscle is not located in the skin of the thorax but is in the lateral region of the neck," Haouzi explained.

Haouzi applied an innocuous and non-painful electrical stimulation to the set of dermatomes that correspond to the diaphragm in the neck of a patient suffering from dyspnea. The patient reported the treatment provided relief from the discomfort of feeling short of breath as long as the stimulation was maintained.

This method is non-invasive since the stimulation is applied to the skin itself and can be performed by the patient at home, given the proper device and instruction.

"Being short of breath doesn't necessarily mean that the respiratory muscles are involved," said Haouzi. "Dyspnea can be generated by many other mechanisms. But at least we can address this specific mechanism involved in many patients with respiratory as well as cardiac disease, giving the patient some relief." Haouzi has filed a provisional patent for this work.

Related Stories

Diltiazem relieves capecitabine-induced chest pain

date Nov 16, 2012

(HealthDay)—Secondary prophylaxis with diltiazem may offer cancer patients relief from capecitabine-induced chest pain and dyspnea and allow them to tolerate capecitabine treatment, according to a study ...

Recommended for you

'Ebola will return', veteran scientist warns

date 5 hours ago

Congolese expert Jean-Jacques Muyembe may be little known to the public, but he has been one of the world's top Ebola investigators since the first epidemic erupted in central Africa in 1976.

Score IDs patients with upper extremity DVT at low risk

date 20 hours ago

(HealthDay)—For patients with upper-extremity deep vein thrombosis (DVT), six easily available factors can be used to create a score that identifies those at low risk of adverse events during the first ...

Combined drug treatment combats kidney disease

date May 29, 2015

A recent discovery by drug researchers whereby coupling specific cell membrane receptors has altered kidney cell function has triggered a re-think of how to treat chronic kidney disease (CKD) more effectively.

Active substance targeting dreaded hospital germs

date May 29, 2015

In the German Center for Infection Research (DZIF), scientists have conducted clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: a highly effective protein from bacteriophages ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.